Short Interest in Moolec Science SA (NASDAQ:MLEC) Increases By 605.0%

Moolec Science SA (NASDAQ:MLEC) was the target of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 57,914 shares, a growth of 605.0% from the February 12th total of 8,215 shares. Currently, 10.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,377,896 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 1,377,896 shares, the short-interest ratio is presently 0.0 days. Currently, 10.0% of the shares of the stock are short sold.

Moolec Science Trading Down 2.0%

NASDAQ MLEC traded down $0.21 on Wednesday, reaching $10.27. 4,989 shares of the company were exchanged, compared to its average volume of 1,769,633. The business’s fifty day moving average price is $7.75 and its 200 day moving average price is $10.04. The stock has a market capitalization of $7.49 million, a P/E ratio of -0.31 and a beta of -0.65. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $157.05.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Moolec Science to a “sell” rating in a research note on Saturday, February 28th.

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC acquired a new position in shares of Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science at the end of the most recent quarter. 0.07% of the stock is currently owned by institutional investors and hedge funds.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.